有關結核
病之法例

如何呈報
結核病個案？

利用「計劃表格」
以監察結核病人之
進度和結果

香港之卡介苗
防疫注射計劃

衞生署胸肺
科年報

有關結核病
的文獻

其他有用之
本地文獻 / 資料

 
 
供醫生之資訊

有關結核病的文獻

(有關資料只供參考，並非表示已包含所有有關結核病的文獻)

2008

  • Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung GM, Law WS, Tam CM, Chan CK, Chang KC. Diabetic control and risk of tuberculosis: a cohort study. Am J Epidemiol 2008; April 8.
  • Chang KC, Leung CC, Yew WW, Lau TY, Tam CM. Hepatotoxicity of pyrazinamide: cohort and case-control analyses. Am J Respir Crit Care Med 2008; Apr 3.
  • Leung CC, Bailey WC, Yew WW. Screening contacts of tuberculosis: overcoming obstacles with an old tool. Am J Respir Crit Care Med 2008;177:939-40.
  • Leung CC, Yew WW. Study on twins: a good tool for infectious diseases? Am J Respir Crit Care Med 2008;177:799-800.
  • Yew WW, Leung CC. Update in tuberculosis 2007. Am J Respir Crit Care Med. 2008 1;177:479-85.
  • Chang KC, Leung CC, Yew WW, Kam KM, Yip CW, Ma CH, Tam CM, Leung EC, Law WS, Leung WM. Peak plasma rifampicin level in tuberculosis patients with slow culture conversion. Eur J Clin Microbiol Infect Dis 2008 Jan 24.
  • Chang KC, Leung CC, Yew WW, Tam CM. Supervised and induced sputum among patients with smear-negative pulmonary tuberculosis. Eur Respir J 2008;31:1085-90.
  • Leung CC, Yam WC, Yew WW, Ho PL, Tam CM, Law WS, Wong MY, Leung M, Tsui D. Comparison of T-Spot. TB and tuberculin skin test among silicotic patients. Eur Respir J 2008;31:266-72.
  • Hui M, Au-Yeang C, Wong KT, Chan CY, Yew WW, Leung CC. Post-antibiotic effects of linezolid and other agents against Mycobacterium tuberculosis. Int J Antimicrob Agents 2008;31:395-6.
  • Yew WW, Chau CH, Wen HK. Linezolid in the treatment of ‘difficult’ multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2008;12:345-6.
  • Lee MS, Leung CC, Kam KM, Wong MY, Leung MC, Tam CM, Leung EC. Early and late tuberculosis risks among close contacts in Hong Kong. Int J Tuberc Lung Dis 2008;12:281-7.
  • Wong MY, Leung CC, Tam CM, Kam KM, Ma CH, Au KF. TB surveillance in correctional institutions in Hong Kong, 1999-2005. Int J Tuberc Lung Dis 2008;12:93-8.
  • Yew WW, Leung CC. Management of multidrug-resistant tuberculosis: Update 2007. Respirology 2008;13:21-46.
  • Wu P, Cowling BJ, Schooling CM, Wong IO, Johnston JM, Leung CC, Tam CM, Leung GM. Age-period-cohort analysis of tuberculosis notifications in Hong Kong from 1961 to 2005. Thorax 2008;63:312-6.

返回頁首

2007

  • Perlman DC, Leung CC, Yew WW. Treatment of tuberculosis in HIV-infected patients: we need to know more. Am J Respir Crit Care Med 2007;175:1102-3.
  • Yew WW, Leung CC. Antituberculosis drugs and hepatotoxicity (letter). Am J Respir Crit Care Med 2007;175:858-9.
  • Chang KC, Leung CC, Tam CM. Towards optimizing treatment for Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2007;175:860.
  • Yew WW, Leung CC. Update in tuberculosis 2006. Am J Respir Crit Care Med 2007;175:541-6.
  • Leung CC, Lam TH, Yew WW. Smoking and tuberculosis: infection, disease, and mortality. Arch Intern Med 2007;167:2008-9.
  • Leung CC, Lam TH, Chan WM, Yew WW, Ho KS, Leung G, Law WS, Tam CM, Chan CK, Chang KC. Lower risk of tuberculosis in obesity. Arch Intern Med 2007;167:1297-304.
  • Leung KH, Yip SP, Wong WS, Yiu LS, Chan KK, Lai WM, Chow EY, Lin CK, Yam WC, Chan KS. Sex – and age- dependent association of SLC11A1 polymorphisms with tuberculosis in Chinese: a case control study. BMC Infect Dis 2007 19;7:19.
  • Ridderhof JC, van Deun A, Kam KM, Narayanan PR, Aziz MA. Roles of laboratories and laboratory systems in effective tuberculosis programmes. Bull World Health Organ 2007;85:354-9.
  • Mak JC, Leung HC, Sham AS, Mok TY, Poon YN, Ling SO, Wong KC, Chan-Yeung M. Genetic polymorphisms and plasma levels of transforming growth factors in patients with tuberculosis in Hong Kong. Cytokine 2007; 40:177-82.
  • Vynnycky E, Borgdorff MW, Leung CC, Tam CM, Fine PE. Limited impact of tuberculosis control in Hong Kong: attributable to high risks of reactivation disease. Epidemiol Infect 2007 Aug 3:1-10.
  • Chang KC, Leung CC, Yew WW, Tam CM. Standard anti-tuberculosis treatment and hepatotoxicity: do dosing schedules matter? Eur Respir J 2007;29:347-51.
  • Leung CC, Yew WW, Law WS, Tam CM, Leung M, Chung YW, Cheung KW, Chan KW, Fu F. Smoking and tuberculosis among silicotic patients. Eur Respir J 2007;29(4):745-50.
  • Pai M, Mohan A, Dheda K, Leung CC, Yew WW, Christopher DJ, Sharma SK. Lethal interaction: the colliding epidemics of tobacco and tuberculosis. Expert Rev Anti Infect Ther. 2007;5:385-91.
  • Chu SF, Tam CM, Wong HS, Kam KM, Lau YL, Chiang AK. Association between RANTES functional polymorphisms and tuberculosis in Hong Kong Chinese. Genes Immun 2007;8:475-9.
  • Lam PK, Wei WI. Medialisation thyroplasty for unilateral vocal cord paralysis associated with chronic pulmonary tuberculosis. Hong Kong Med J 2007;13:330-1.
  • Leung ECC, Leung CC, Tam CM. Delayed presentation and treatment of newly diagnosed pulmonary tuberculosis patients in Hong Kong. Hong Kong Med J 2007;13:221-7.
  • Angra P, Beex-Bleumink M, Gilpin C, Joloba M, Jost K, Kam KM, Kim SJ, Lumb R, Mitarai S, Ramsay A, Ridderhof J, Rieder HL, Selvakumar N, van Beers S, van Cleff M, Van Deun A, Vincent V. Ziehl-Neelsen staining: strong red on weak blue, or weak red under strong blue? Int J Tuberc Lung Dis 2007;11:1160-1.
  • Tam WO, Yew WW, Yam WC, Yuen KY, Wong PC, Tse TF. Pacemaker infections due to rapidly growing mycobacteria: further experience. Int J Tuberc Lung Dis 2007;11:118.
  • Wong HY, Chau CH, Yew WW. Moxifloxacin-induced arthropathy. Int J Tuberc Lung Dis 2007;11:117.
  • Lui SL, Yip T, Tse KC, Chan TM, Lai KN, Lo WK. Tuberculosis lymphadenitis in patients undergoing continuous ambulatory peritoneal dialysis. Int Urol Nephrol 2007;39:971-4.
  • Chow KM, Chan NP, Chui KL, Szeto CC. Pancytopenia in a patient with tuberculosis peritonitis. Intern Med J 2007;37:277-7.
  • Chan-Yeung M, Dai DL, Cheung AH, Chan FH, Kam KM, Tam CM, Leung CC. Tuberculin skin test reaction and body mass index in old age home residents in Hong Kong. J Am Geriatr Soc 2007;55:1592-7.
  • Chan RC, Hui M, Chan EW, Au TK, Chin ML, Yip CK, Auyeang CK, Yeung CY, Kam KM, Yip PC, Cheng AF. Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J Antimicrob Chemother 2007;59:866-73.
  • Wong WM, Lai KC, Yiu WC, Wong BC, Chan FL, Lai CL. Intestinal tuberculosis mimicking fistulizing Crohn’s disease. J Gastroenterol Hepatol 2007;22:137-9.
  • Chan AC, Lo CM, Ng KK, Chan SC, Fan ST. Implications for management of Mycobacterium tuberculosis infection in adult-to-adult live donor liver transplantation. Liver Int 2007 ;27; 81-5.
  • Leung CC, Chan CK, Tam CM. HIV-related TB and adverse drug events. Thorax 2007;62:923-4.

返回頁首

2006

  • Yew WW, Leung CC. Update in tuberculosis 2005. Am J Respir Crit Care Med 2006;173:491-8.
  • Yew WW, Leung CC. Prognostic significance of early weight gain in underweight patients with tuberculosis. Am J Respir Crit Care Med 2006;174:236-7.
  • Chang KC, Leung CC, Yew WW, Chan SL, Tam CM. Dosing schedules of 6-month regimens and relapse for pulmonary tuberculosis. Am J Respir Crit Care Med 2006;174:1153-8.
  • Leung ET, Ho PL, Yuen KY, Woo WL, Lam TH, Kao RY, Seto WH, Yam WC. Molecular characterization of isoniazid resistance in Mycobacterium tuberculosis: identification of a novel mutation in inhA. Antimicrob Agents Chemother 2006;50:1075-8.
  • Leung CC, Yew WW, Chang KC, Tam CM, Chan CK, Law WS, Wong MY, Lee SN, Leung M. Risk of active tuberculosis among schoolchildren in Hong Kong. Arch Pediatr Adolesc Med 2006;160:247-51.
  • Wong JS, Ng CS, Lee TW, Yim AP. Bronchoscopic management of airway obstruction in pediatric endobronchial tuberculosis. Can Respir J 2006;13:219-21.
  • Kam KM, Yip CW, Tse LW, Leung KL, Wong KL, Kow WM, Wong WS. Optimization of variable number tandem repeat typing set for differentiating Mycobacterium tuberculosis strains in the Beijing family. FEMS Microbiol Lett. 2006;256:258-65.
  • Ho MH, Ho CK, Chong LY. Atypical mycobacterial cutaeous infections in Hong Kong: 10-year retrospective study. Hong Kong Med J 2006;12:21-6.
  • Chan RYC, Kwok AKH. Ocular toxicity of ethambutol. Hong Kong Med J 2006;12:56-60.
  • Leung VKS, Law ST, Lam CW, Luk ISC, Chau TN, Loke TKL, Chan WH, Lam SH. Intestinal tuberculosis in a regional hospital in Hong Kong: a 10-year experience. Hong Kong Med J 2006;12:264-71.
  • Ho CK, Ho MH, Chong LY. Cutaneous tuberculosis in Hong Kong: an update. Hong Kong Med J 2006;12:272-7.
  • Leung VKS, Chu W, Lee VHM, Chau TN, Law ST, Lam SH. Tuberculosis intestinal perforation during anti-tuberculous treatment. Hong Kong Med J 2006;12:313-5.
  • Tam CM, Leung CC. Occupational tuberculosis: a review of the literature and the local situation. Hong Kong Med J 2006;12:448-55.
  • Leung VKS, Chan WH, Chow TL, Luk ISC, Chau TN, Loke TKL. Oesophageal tuberculosis mimicking oesophageal carcinoma. Hong Kong Med J 2006;12:473-6.
  • Meher R, Agarwal S, Singh I. Tuberculous retropharyngeal abscess in an HIV patient. Hong Kong Med J 2006;12:483-5.
  • Yip CW, Leung KL, Wong D, Cheung DT, Chu MY, Tang HS, Kam KM. Denaturing HPLC for high-throughput screening of rifampicin-resistant Mycobacterium tuberculosis isolates. Int J Tuberc Lung Dis 2006;10:625-30.
  • Yu WC, Lai ST, Chiu MC, Chau TN, Ng TK, Tam CM. Lamivudine enabled isoniazid and rifampicin treatment in pulmonary tuberculosis and hepatitis B co-infection. Int J Tuberc Lung Dis 2006;10:824-6.
  • Chan-Yeung M, Cheung AHK, Dai DLK, Chan FHW, Kam KM, Tam CM, Leung CC. Prevalence and determinants of positive tuberculin reactions of residents in old age homes in Hong Kong. Int J Tuberc Lung Dis 2006;10:892-8.
  • Chan-Yeung M, Chan FHW, Cheung AHK, Dai DLK, Chu LW, Lam WK, Leung CC, Kam KM, Tam CM. Prevalence of tuberculous infection and active tuberculosis in old age homes in Hong Kong. J Am Geriatr Soc 2006;54:1334-40.
  • Yam WC, Yuen KY, Kam SY, Yiu LS, Chan KS, Leung CC, Tam CM, Ho PO, Yew WW, Seto WH, Ho PL. Diagnostic application of genotypic identification of mycobacteria. J Med Micriobiol 2006;55:529-36.
  • Kam KM, Yip CW, Cheung TL, Tang HS, Leung OC, Chan MY. Stepwise decrease in moxifloxacin susceptibility amongst clinical isolates of multidrug-resistant Mycobacterium tuberculosis: correlation with ofloxacin susceptibility. Microb Drug Resist 2006; 12:7-11.
  • Chan-Yeung M, Kam KM, Leung CC, Wang J, Yew WW, Lam CW, Tam CM. Population-based prospective molecular and conventional epidemiological study of tuberculosis in Hong Kong. Respirology 2006;11(4):442-8.
  • Yew WW, Leung CC. Antituberculosis drugs and hepatotoxicity. Respirology 2006;11:699-707.
  • Davies PD, Yew WW, Ganguly D, Davidow AL, Reichman LB, Dheda K, Rook GA. Smoking and tuberculosis: the epidemiological association and immunopathogenesis. Trans R Soc Trop Med Hyg 2006;100:291-8.

返回頁首

2005

  • Ichikawa M, Nakahara S, Wakai S. Lowered tuberculosis notifications and deterred health care seeking during the SARS epidemic in Hong Kong. Am J Public Health 2005;95:933-4.
  • Yew WW, Leung CC. Are some people not safer after successful treatment of tuberculosis? Am J Respir Crit Care med 2005;171:1324-5.
  • Nemery B, Yew WW, Albert R, Brun-Buisson C, Macnee W, Martinez FJ, Angus DC, Abraham E. Tuberculosis, nontuberculous lung infection, pleural disorders, pulmonary function, respiratory muscles, occupational lung disease, pulmonary infections, and social issues in AJRCCM in 2004. Am J Respir Crit Care Med 2005;171:554-62.
  • Cheng VC, Yew WW, Yuen KY. Molecular diagnostics in tuberculosis. Eur J Clin Microbiol Infect Dis 2005;24:711-20.
  • Tso HW, Ip WK, Chong WP, Tam CM, Chiang AKS, Lau YL. Association of interferon gamma and interleukin 10 genes with tuberculosis in Hong Kong Chinese. Genes Immun 2005;6:358-63.
  • Mok CC. Consensus statements on the indications and monitoring of anti-tumour necrosis factor (TNF) therapy for rheumatic diseases in Hong Kong. Hong Kong Bull Rhemat Dis 2005;5:1-7.
  • Leung CC, Yew WW, Chan TY, Tam CM, Chan CY, Chan CK, Tang N, Chang KC, Law WS. Seasonal pattern of tuberculosis in Hong Kong. Int J Epidemiol 2005;34:924-30.
  • Leung CC, Chan CK, Tam CM, Yew WW, Kam KM, Au KF, Tai LB, Leung SM, Ng J. Chest radiograph screening for tuberculosis in a Hong Kong prison. Int J Tuberc Lung Dis 2005;9:627-32.
  • Wong MY, Leung CC, Tam CM, Lee SN. Directly observed treatment of tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2005;9:443-9.
  • Chan-yeung M, Yeh AG, Tam CM, Kam KM, Leung CC, Yew WW, Lam CW. Socio-demographic and geographic indicators and distribution of tuberculosis in Hong Kong: a spatial analysis. Int J Tuberc Lung Dis 2005;9:1320-6.
  • Lau KK, Yu IT, Chan AC, Wong LK, Tam CM, Sheng B, Li HL; Hong Kong Tuberculous Meningitis Study Group. A registry of tuberculous meningitis in Hong Kong. Int J Tuberc Lung Dis 2005;9:1391-7.
  • Kam KM, Yip CW, Tse LW, Wong KL, Lam TK, Kremer K, Au BK, van Soolingen D. Utility of mycobacterial interspersed repetitive unit typing for differentiating multidrug-resistant Mycobacterium tuberculosis isolates of the Beijing family. J Clin Microbiol 2005;43:306-13.
  • Kremer K, Au BK, Yip PC, Skuce R, Supply P, Kam KM, van Soolingen D. Use of variable-number tandem-repeat typing to differentiate Mycobacterium tuberculosis Beijing family isolates from hong Kong and comparison with IS6110 restriction fragment length polymorphism typing and spoligotyping. J Clin Microbiol 2005;43:314-20.
  • Chiang CY, Rieder HL, Kim SJ, Kam KM, Dawson D, Lin TP, Luh KT. Quality of sputum smear microscopy in Taiwan. J Formos Med Assoc 2005;104:502-6.
  • Leung CC, Chang KC, Law WS, Yew WW, Tam CM, Chan CK, Wong MY. Determinants of spirometric abnormalities among silicotic patients in Hong Kong. Occup Med 2005;55:490-3.
  • Law WS, Tam CM, Leung CC. How do we tackle latent tuberculosis infection in immunocompetent persons? Public Health & Epidemiology Bulletin 2005;14(3)36-40.
  • Wong CF, Leung SK, Yew. Percentage reduction of pleural effusion as a simple predictor of pleural scarring in tuberculous pleuritis. Respirology 2005;10:515-9.
  • Wong PC. Management of tuberculous pleuritis: can we do better? Respirology 2005;10:144-8.
  • Moore Gillon J. Tuberculin testing, BCG, and tuberculosis today (ed). Thorax 2005;60:90-1.
  • Leung CC, Yew WW, Tam CM, Chan CK, Chang KC, Law WS, Lee SN, Wong MY, Au KF. Tuberculin response in BCG vaccinated schoolchildren and the estimation of annual risk of infection in Hong Kong. Thorax 2005;60:124-9.

返回頁首

2004

  • Leung CC, Li T, Lam TH, Yew WW, Law WS, Tam CM, Chan WM, Chan CK, Ho KS, Chang KC. Smoking and tuberculosis among the elderly in Hong Kong. Am J Respir Crit Care Med 2004;170:1027-33.
  • Vernon AA, Iademarco MF. In the treatment of TB, you get what you pay for (ed). Am Rev Respir Crit Care Med 2004;170:040-2.
  • Chang KC, Leung CC, Yew WW, Ho SC, Tam CM. A nested case-control study on treatment-related risk factors for early relapse of tuberculosis. Am J Respir Crit Care Med 2004;170:1124-30.
  • Leung CC, Chan CK, Yew WW. Side effects of antituberculosis therapy. Am J Respir Crit Care Med 2004;169:1168-9; author reply 1169.
  • Chan CY, Au-Yeang C, Yew WW, Leung CC, Cheng AF. In vitro postantibiotic effects of rifapentine, isoniazid, and moxifloxacin against Mycobacterium tuberculosis. Antimicrob Agents Chemother 2004;48:340-3.
  • Cheng AF, Yew WW, Chan EW, Chin ML, Hui MM, Chan RC. Multiplex PCR amplimer conformation analysis for rapid detection of gyrA mutations in fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates. Antimicrob Agents Chemother 2004;48:596-601.
  • Chen ML, Yu WC, Lam CW, Au KM, Kong FY, Chan AY. Diagnostic value of pleural fluid adenosine deaminase activity in tuberculosis pleurisy. Clin Chim Acta 2004;341:101-7.
  • Yam WC, Cheng VC, Hui WT, Wang LN, Seto WH, Yuen KY. Direct detection of Mycobacterium tuberculosis in clinical specimens using single-tube biotinylated nested polymerase chain reaction-enzyme linked immunoassay (PCR-ELISA). Diagn Microbiol Infect Dis 2004;48:271-5.
  • Kam KM, Yip CW. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong 1995-2002 after the implementation of DOTS-plus. Int J Tuberc Lung Dis 2004;8:760-6.
  • Leung CC, Yew WW, Tam CM, Chan CK, Chang KC, Law WS, Wong MY, Au KF. Socio-economic factors and tuberculosis: a district-based ecological analysis in Hong Kong. Int J Tuberc Lung Dis 2004;8:958-64.
  • Kim SJ, Espinal MA, Abe C, Bai GH, Boulahbal F, Fattorin L, Gilpin C, Hoffner S, Kam KM, Martin-Casabona N, Rigouts L, Vincent V. Is second-line anti-tuberculosis drug susceptibility testing reliable? Int J Tuberc Lung Dis 2004;8:1157-8.
  • Chang KC, Leung CC, Tam CM. Risk factors for defaulting from anti-tuberculosis treatment under directly observed treatment in Hong Kong. Int J Tuberc Lung Dis 2004;8:1492-8.
  • Chan RCY, Hui M, Chan EWC, Au TK, Chin ML, Yip CK, AuYeang CKW, Yeung CYL, Kam KM, Yip PCW, Cheng AFB. Genetic and phenotypic characterisation of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J Antimicrob Chemother 2004;54:593-602.
  • Chu CM, Woo PC, Chong KT, Leung WS, Chan VL, Yuen KY. Association of presence of Aspergillus antibodies with hemoptysis in patients with old tuberculosis or bronchiectasis but no radiologically visible mycetoma. J Clin Microbiol 2004;42:665-9.
  • Yam WC, Tam CM, Leung CC, Tong HL, Chan KH, Leung ET, Wong KC, Yew WW, Seto WH, Yuen KY, Ho PL. Direct detection of rifampin-resistant mycobacterium tuberculosis in respiratory specimens by PCR-DNA sequencing. J Clin Microbiol 2004;42:4438-43.
  • Cheng VC, Yam WC, Hung IF, Woo PC, Lau SK, Tang BS, Yuen KY. Clinical evaluation of the polymerase chain reaction for the rapid diagnosis of tuberculosis. J Clin Pathol 2004;57:281-5.
  • Tso HW, Lau YL, Tam CM, Wong HS, Chiang AK. Associations between IL12B polymorphisms and tuberculosis in the Hong Kong Chinese population. J Infect Dis 2004;190:913-9.
  • Chomej P, Bauer K, Bitterlich N, Hui DSC, Chan KS, Gosse H, Schauer J, Hoheisel g, Sack U. Differential diagnosis of pleural effusions by fuzzy-logic-based analysis of cytokines. Respir Med 2004;98:308-17.

返回頁首

2003

  • Au WY, Cheng VC, Ho PL, Yuen KY, Hung I, Ma SY, Lie AK, Liang R, Kwong YL. Nontuberculous mycobacterial infections in Chinese hematopoietic stem cell transplantation recipients. Bone Marrow Transplant 2003;32:709-14.3
  • Leung CC, Law WS, Chang KC, Tam CM, Yew WW, Chan CK, Wong MY. Initial experience on rifampin and pyrazinamide vs isoniazid in the treatment of latent tuberculosis infection among patients with silicosis in Hong Kong. Chest 2003;124:2112-8.
  • Yew WW, Chan CK, Leung CC, Chau CH, Tam CM, Wong PC, Lee J. Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong. Chest 2003;124:1476-81.
  • Wong DA, Yip PC, Tse DL, Tung VW, Cheung DT, Kam KM. Routine use of a simple low-cost genotypic assay for the identification of mycobacteria in a high throughput laboratory. Diagn Microbiol Infect Dis 2003;47:421-6.
  • Cheng VC, Woo PC, Lau SK, Cheung CH, Yung RW, Yam LY, Yuen KY. Peripartum tuberculosis as a form of immunorestitution disease. Eur J Clin Microbiol Infect Dis. 2003;22:313-7. Review.
  • Cheng VC, Yam WC, Woo PC, Lau SK, Hung IF, Wong SP, Cheung WC, Yuen KY. Risk factors for development of paradoxical response during antituberculosis therapy in HIV-negative patients. Eur J Clin Microbiol Infect Dis 2003;22:597-602.
  • El Sony Asma, Beyers N, Enarson D, Chan-Yeung M. Tuberculosis in women. Eur Respir J Monograph 25- 2003; 8:152-166.
  • Davies PD, Yew WW. Recent developments in the treatment of tuberculosis. Expert Opin Investig Drugs 2003;12:1297-312.
  • So SY. The continued threat of tuberculosis. Hong Kong Med J 2003;9:77.
  • Tam CM, Leung CC, Noertjojo K, Chan SL, Chan-Yeung M. Tuberculosis in Hong Kong - patient characteristics and treatment outcome. Hong Kong Med J 2003;9:83-90.
  • Chan-yeung M, Noertjojo K, Leung CC, Chan SL, Tam CM. Prevalence and predictors of default from tuberculosis treatment in Hong Kong. Hong Kong Med J 2003;9:263-8.
  • Chan KH, Ho PL, Cheung RT, Tsang KL, Fong GC, Cheng PW, Ho SL. Tuberculous meningitis with tuberculomata presenting as postpartum pyrexia of unknown origin. Hosp Med 2003;64:306-7.
  • Yew WW, Tam CM. DOTS and DOTS-Plus in Hong Kong [letter]. Int J Tuberc Lung Dis 2003;7(1):99-100.
  • Yew WW, Leung SK. Prediction of residual pleural thickening in tuberculous pleural effusion. Int J Tuberc Lung Dis 2003;7:199-200.
  • Chau CH, Yew WW, Lam FM. Pleural effusion due to Mycobacterium gordonae infection. Int J Tuberc Lung Dis 2003;7:503.
  • Leung CC, Yew WW, Chan CK, Tam CM, Lam CW, Chang KC, Chau CH, Lau KS, Law WS. Smoking and tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2003;7:980-6.
  • Chan-Yeung M, Tam CM, Wong H, Leung CC, Wang J, Yew WW, Lam CW, Kam KM. Molecular and conventional epidemiology of TB in Hong Kong: a population-based prospective study. J Clin Microb 2003;41:2706-8.
  • Lee J, Yew WW, Wong CF, Wong PC, Chiu CS. Multidrug-resistant tuberculosis in a lung transplant recipient. J Heart Lung Transplant 2003;22:1168-73.
  • Leung ET, Kam KM, Chiu A, Ho PL, Seto WH, Yuen KY, Yam WC. Detection of katG Ser315Thr substitution in respiratory specimens from patients with isoniazid-resistant Mycobacterium tuberculosis using PCR-RFLP. J Med Microbiol 2003;52(11):999-1003.
  • Wong CF, Yew WW, Leung SK, Chan CY, Hui M, Au-Yeang C, Cheng AF. Assay of pleural fluid interleukin-6, tumour necrosis factor-alpha and interferon-gamma in the diagnosis and outcome correlation of tuberculous effusion. Respir Med 2003;97:1289-95.

返回頁首

2002

  • Kam KM, Yip CW, Tse LW, Leung OC, Sin LP, Chan MY, Wong WS. Trends in multidrug-resistant Mycobacterium tuberculosis in relation to sputum smear positivity in Hong Kong, 1989-1999. Clin Infect Dis 2002;34:324-9.
  • Yew WW. Clinically significant interactions with drugs used in the treatment of tuberculosis. Drug Saf 2002;25:111-33.
  • Cheng VC, Ho PL, Lee RA, Chan KS, Chan KK, Woo PC, Lau SK, Yuen KY. Clinical spectrum of paradoxical deterioration during antituberculosis therapy in non-HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002;21:803-9.
  • Yuen KY, Woo PC. Tuberculosis in blood and marrow transplant recipients. Hematol Oncol 2002;20:51-62. Review.
  • Chang KC, Leung CC, Tam CM. A clinical approach to tuberculosis. Hong Kong Med Ass CME Bull 2002;1-11.
  • Lee WY, Pang KY, Wong CK. Brain tuberculoma in Hong Kong. Hong Kong Med J 2002;8:52-6.
  • Leung ECC, Tam CM. Comorbidities among patients with tuberculosis in Hong Kong. Hong Kong Practitioner 2002;24:170-8.
  • Tai LB, Chan CK, Li PCK, Tam CM. "A patient with TB exacerbation" HKTS/ACCP newsletter 2002;12:16-21.
  • Vernon A, Burman W, Horsburgh CR. Another step on the path to better TB therapies (ed). Int J Tuberc Lung Dis 2002;6:1-2.
  • Tam CM, Chan SL, Kam KM, Goodall RL, Mitchison DA. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures. Int J Tuberc Lung Dis 2002;6:3-10.
  • Chan-Yeung M, Noertjojo K, Chan SL, Tam CM. Sex differences in tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2002;6:11-8.
  • Noertjojo K, Tam CM, Chan SL, Tan J, Chan-Yeung M. Contact examination for tuberculosis in Hong Kong is useful. Int J Tuberc Lung Dis 2002;6:19-24.
  • Yew WW, Chau CH. Utility of fluoroquinolones in multidrug-resistant tuberculosis--a balanced view? Int J Tuberc Lung Dis 2002;6174-5; author reply 175-6.
  • Chan-Yeung M, Noertjojo K, Tan J, Chan SL, Tam CM. Tuberculosis in the elderly in Hong Kong. Int J Tuberc Lung Dis 2002;6:771-9.
  • Noertjojo K, Tam CM, Chan SL, Chan-Yeung MM. Extra-pulmonary and pulmonary tuberculosis in Hong Kong. Int J Tuberc Lung Dis 2002;6:879-86.
  • Yew WW, Chan E, Chan CY, Cheng AF. Genotypic and phenotypic resistance of Mycobacterium tuberculosis to rifamycins and fluoroquinolones. Int J Tuberc Lung Dis 2002;6:936-7.
  • Yew WW, Chau CH, Lee J. Superficial fungal infection of the skin during treatment of tuberculosis. Int J Tuberc Lung Dis 2002;6:1132.
  • Leung CC, Yew WW, Chan CK, Chau CH, Tam CM, Lam CW, Tam WO, Lau KS, Liu WT. Tuberculosis in older people: a retrospective and comparative study from Hong Kong. J Am Geriatr Soc 2002; 50:1219-26.
  • Chang KC, Leung CC, Tam CM. Recent trend of tuberculosis in Hong Kong. Public Health & Epidemiology Bulletin 2002;11:69-75.
  • Tam LS, Li EK, Wong SM, Szeto CC. Risk factors and clinical features for tuberculosis among patients with systemic lupus erythematosus in Hong Kong. Scand J Rheumatol. 2002;31:296-300.

返回頁首

2001

  • Lui SL, Tang S, Li FK, Choy BY, Chan TM, Lo WK, Lai KN. Tuberculosis infection in Chinese patients undergoing continuous ambulatory peritoneal dialysis. Am J Kidney Dis 2001;38:1055-60.
  • Chan CY, Au-Yeang C, Yew WW, Hui M, Cheng AF. Postantibiotic effects of antituberculosis agents alone and in combination. Antimicrob Agents Chemother 2001;45:3631-4.
  • Lam HT, Ho sy, Hedley AJ, Mak KH, Peto R. Mortality and smoking in Hong Kong: case-control study of all adult deaths in 1998. BMJ 2001;323:361.
  • Yew WW. Therapeutic drug monitoring in antituberculosis chemotherapy: clinical perspectives. Clin Chim Acta 2001;313:31-6.
  • Yew WW, Tong SC, Lui KS, Leung SK, Chau CH, Wang EP. Comparison of MB/BacT system and agar proportion method in drug susceptibility testing of Mycobacterium tuberculosis. Diagn Microbiol Infect Dis 2001;39:229-32.
  • Seto WH. Preventing nosocomial Mycobacterium tuberculosis transmission in international settings. Emerg Infect Dis 2001;7:245-8.
  • Yuen MC, Tung WK. An uncommon cause of foot ulcer: tuberculosis osteomyelitis. Emerg Med J 2001;18:140-1.
  • Chan MY, Borgdorff M, Yip CW, de Haas PE, Wong WS, Kam KM, Van Soolingen D. Seventy percent of the Mycobacterium tuberculosis isolates in Hong Kong represent the Beijing genotype. Epidemiol Infect 2001;127:169-71.
  • Chan SL, Lee YT, Chan YC, Au YK, Yeung VT. A young male patient with persistent fever due to tuberculous peritonitis. Hong Kong Med J 2001;7:209-12.
  • Lee J, Yew WW, Wong PC, Fu KH. Non-hodgkin's pleural lymphoma in long-standing tuberculous pyothorax mimicking suppuration. Int J Infect Dis 2001;5:167-9.
  • Yew WW. Risk factors for hepatotoxicity during anti-tuberculosis chemotherapy in Asian populations. Int J Tuberc Lung Dis 2001;5:99-100.
  • Chang KC, Leung CC, Tam CM. Tuberculosis risk factors in a silicotic cohort in Hong Kong. Int J Tuberc Lung Dis 2001;5:177-84.
  • Yew WW, Wong CF, Chan CY, Cheung SW, Cheng AF. Serological diagnosis of tuberculosis using IgA detection against the mycobacterial kp-90 antigen. Int J Tuberc Lung Dis 2001;5:585-6.
  • Leung CC, Tam CM, Chan SL, Chan-Yeung M, Chan CK, Chang KC. Efficacy of the BCG revaccination programme in a cohort given BCG vaccination at birth in Hong Kong. Int J Tuberc Lung Dis 2001;5:717-23.
  • Espinal MA, Gupta R, Raviglione MC. The future may not be so dark (ed). Int J Tuberc Lung Dis 2001;5:787-8.
  • Kam KM, Yip CW. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment. Int J Tuberc Lung Dis 2001;5:815-23.
  • Yew WW, Chau CH, Lee J, Wong PC, Leung CK. Hoarseness due to recurrent laryngeal nerve palsy from intrathoracic mycobacteriosis. Int J Tuberc Lung Dis 2001;5:1074-5.
  • Green RA. Efficacy of the BCG revaccination programme in Hong Kong (letter). Int J Tuberc Lung Dis 2001;5(12):1161.
  • Fine PEM. Efficacy of the BCG revaccination programme in Hong Kong (letter). Int J Tuberc Lung Dis 2001;5(12):1161-2.
  • Wong DA, Yip PC, Cheung DT, Kam KM. Simple and rational approach to the identification of Mycobacterium tuberculosis, Mycobacterium avium complex species, and other commonly isolated mycobacteria. J Clin Microbiol 2001;39:3768-71.
  • Hui M, Cheung SW, Chan CY, Cheng AF. Rapid identification of Mycobacterium tuberculosis complex from Bactec 12B broth cultures originating from non-respiratory secretion specimens: comparison between Accuprobe and in-house polymerase chain reaction. Pathology 2001;33:61-5.
  • Chu CM, Yung CY, Leung WS, Chan VL, Leung EM. Early unplanned readmission of patients with newly diagnosed tuberculosis discharged from acute hospital to ambulatory treatment. Respirology 2001;6:145-9.
  • Wong GWK, Hui DSC, Tam CM, Chan HH, Fok TF, Chan-Yeung M, Lai CKW. Asthma, atopy and tuberculin responses in Chinese schoolchildren in Hong Kong. Thorax 2001;56:770-3.
  • Hoheisel G, Sach U, Hui DS, Huse K, Chan KS, Chan KK, Hartwig K, Schuster E, Scholz GH, Schauer J. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis. Tuberculosis (Edinb) 2001;81:203-9.

返回頁首

2000

  • Yew WW, Chan CK, Chau CH, Tam CM, Leung CC, Wong PC, Lee J. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens. Chest. 2000;117:744-51.
  • Lau YL, Chan GC, Ha SY, Hui YF, Yuen KY. The role of phagocytic respiratory burst in host defense against Mycobacterium tuberculosis. Clin Infect Dis 1998;26:226-7.
  • Wong WM, Wu PC, Yuen MF, Cheng CC, Yew WW, Wong PC, Tam CM, Leung CC, Lai CL. Antituberculosis drug-related liver dysfunction in chronic hepatitis B infection. Hepatology 2000; 31:201-6.
  • Lau KK, Yu TS, Chan CK, Tam CM. The use of ethambutol has lowered the 2-year mortality rate in patients with tuberculous meningitis [letter]. Hong Kong Med J 2000;6:329-30.
  • Tam CM, Leung CC. Cessation of the BCG revaccination programme for primary school children in Hong Kong. Public Health & Epidemiology Bulletin Vol. 9 (3), Aug 2000: 25-27.
  • Taylor WR, Zumla A. Referral times of Vietnamese refugees with tuberculosis in camps in Hong Kong. Int J Tuberc Lung Dis 2000;4:350-5.
  • Espinal MA, Kim SJ, Suarez PG, Kam KM, Khomenko AG, Migliori GB, Baez J, Kochi A, Dye C, Raviglione MC. Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries. JAMA 2000;283:2537-45.
  • Sirgel FA, Donald PR, Odhiambo J, Githui W, Umapathy KC, Paramasivan CN, Tam CM, Kam KM, Lam CW, Sole KM, Mitchison DA. A multicentre study of the early bactericidal activity of anti-tuberculosis drugs. J Antimicrob Chemother. 2000;45:859-70.
  • Tam CM, Chan SL, Kam KM, Sim E, Staples D, Sole KM, Al-Ghusein H, Mitchison DA. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Interim report: no activity of isoniazid in the continuation phase. Int J Tuberc Lung Dis 2000;4:262-7.
  • Dye C, Williams BG. Criteria for the control of drug-resistant tuberculosis.Proc Natl Acad Sci 2000;97:8180-5.
  • Chan CK, Leung SM, Lee KC, Li R, Tam CM, Leung CC, Law WS. An unusual case of double tuberculous broncho-oesophageal fistulas in an adult. Respirology 2000;5:397-401.
  • Lee MP, Chan JW, Ng KK, Li PC. Clinical manifestations of tuberculosis in HIV-infected patients. Respirology 2000;5:423-6.
  • Ho PL, Chim CS, Yuen KY. Isolated splenic tuberculosis presenting with pyrexia of unknown origin. Scand J Infect Dis 2000;32:700-1.

返回頁首

1999

  • Kam KM, Yip CW, Chan MY, Mok CY, Wong WS. IS6110 dot blot hybridization for the identification of Mycobacterium tuberculosis complex. Diagn Microbiol Infect Dis 1999;33:13-8.
  • Yew WW, Chau CH, Lee J, Leung CK. Is inhaled corticosteroid useful as adjunctive management in tuberculous pyrexia? Drugs Exp Clin Res 1999;25:179-84.
  • Yew WW, Cheung SW, Chau CH, Chan CY, Leung CK, Cheng AF, Wong CF. Serum pharmacokinetics of antimycobacterial drugs in patients with multidrug-resistant tuberculosis during therapy. Int J Clin Pharmacol Res 1999;19:65-71.
  • Ho TTY, Wong KH, Lee SS. Low yield of chest radiography in screening for active pulmonary tuberculosis in HIV-infected patients in Hong Kong. Int J STD AIDS 1999;10:409-12.
  • Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999;282:677-86.
  • Leung CC, Tam CM. Guidance notes for notification of tuberculosis. Public Health & Epidemiology Bulletin 1999;8:36-9.
  • Chan TY. Seasonal variations in vitamin D status and the incidence of tuberculosis in different countries. Respiration 1999;66:196.
  • Cheng AF, Tai VH, Li MS, Chan CH, Wong CF, Yew WW, Hui M, Chan CY, Lee JC. Improved recovery of Mycobacterium tuberculosis from pleural aspirates: bedside inoculation, heparinized containers and liquid culture media. Scand J Infect Dis 1999;31:485-7.

返回頁首

1998

  • Tocque K, Bellis MA, Tam CM, Chan SL, Syed Q, Remmington T, Davies PD. Long-term trends in tuberculosis. Comparison of age-cohort data between Hong Kong and England and Wales. Am J Respir Crit Care Med 1998;158:484-8.
  • Tam CM, Chan SL, Lam CW, Leung CC, Kam KM, Morris JS, Mitchison DA. Rifapentine and isoniazid in the continuation phase of treating pulmonary tuberculosis. Initial report. Am J Respir Crit Care Med 1998;157:1726-33.
  • Chan CY, Tsang DS, Chan TL, Yew WW, Cheung SW, Cheng AF. Detection of fluoroquinolones in urinary specimens from patients undergoing anti-tuberculous therapy. Chemotherapy 1998;44:7-11. Erratum in: Chemotherapy 1998;44:180.
  • Wong CF, Yew WW, Wong PC, Lee J. A case of concomitant tuberculosis and sarcoidosis with mycobacterial DNA present in the sarcoid lesion. Chest 1998;114:626-9.
  • Yam WC, Yuen KY, Seto WH. Direct detection of Mycobacterium tuberculosis in respiratory specimens using an automated DNA amplification assay and a single tube nested polymerase chain reaction (PCR). Clin Chem Lab Med 1998;36:597-9.
  • Tam CM. Rifapentine - a viewpoint. Drugs 1998;56:617.
  • The Tuberculosis Control Coordinating Committee of the Hong Kong Department of Health and the Tuberculosis Subcommittee of the Coordinating Committee in Internal Medicine of the Hospital Authority, Hong Kong. Chemotherapy of tuberculosis in Hong Kong: a consensus statement. Hong Kong Med J 1998;4:315-20.
  • Mak W, Cheung RTF, Ho SL, Tsang KL, Fong GCY. Tuberculous meningitis in Hong Kong: experience in a regional hospital. Int J Tuberc Lung Dis 1998;2:1040-3.
  • Yew WW, Chau CH. Fluoroquinolones and tuberculosis. Int J Tuberc Lung Dis 1998;2:1050-2.
  • Wong CF, Yew WW, Chan CY, Au LY, Cheung SW, Cheng AF. Rapid diagnosis of smear-negative pulmonary tuberculosis via fibreoptic bronchoscopy: utility of polymerase chain reaction in bronchial aspirates as an adjunct to transbronchial biopsies. Respir Med 1998;92:815-9.
  • Yew WW. Therapeutic drug monitoring in antituberculosis chemotherapy. Ther Drug Monit 1998;20:469-72.

返回頁首

1997

  • Yew WW, Chau CH Future directions in the development of new antitubercular drugs. Where do we go from here? Drugs Aging 1997;10:405-10.
  • Yew WW, Au KF, Lee J, Chau CH . Levofloxacin in the treatment of drug-resistant tuberculosis. Int J Tuberc Lung Dis 1997;1:89.
  • Tam CM, Chan SL, Lam CW, Dickinson JM, Mitchison DA. Bioavailability of Chinese rifapentine during a clinical trial in Hong Kong. Int J Tuberc Lung Dis 1997;1:411-6.
  • Ho YI, Chan CY, Cheng AF. In-vitro activities of aminoglycoside-aminocyclitols against mycobacteria. J Antimicrob Chemother 1997;40:27-32.
  • Yuen KY, Yam WC, Wong LP, Seto WH. Comparison of two automated DNA amplification systems with a manual one-tube nested PCR assay for diagnosis of pulmonary tuberculosis. J Clin Microbiol 1997;35:1385-9.
  • Yuen KY, Chan KS, Chan CM, Ho PL, Ng MH. Monitoring the therapy of pulmonary tuberculosis by nested polymerase chain reaction assay. J Infect 1997;34:29-33.
  • Sun RY, Senok AC, Ho A, Oppenheimer SJ, Davies DP. Meningitis in Hong Kong children, with special reference to the infrequency of haemophilus and meningococcal infection. J Paediatr Child Health 1997;33:296-9.
  • Yuen AP, Wong SH, Tam CM, Chan SL, Wei WI, Lau SK. Prospective randomized study of thrice weekly six-month and nine-month chemotherapy for cervical tuberculous lymphadenopathy. Otolaryngol Head Neck Surg 1997;116:189-92.

返回頁首

1996

  • Yew WW, Chau CH, Leung S. Anti-tuberculosis drugs and liver toxicity. Eur Respir J 1996;9:389-90.
  • Woo J, Chan HS, Hazlett CB, Ho SC, Chan R, Sham A, Davies PD. Tuberculosis among elderly Chinese in residential homes: tuberculin reactivity and estimated prevalence. Gerontology 1996;42:155-62.
  • Lau KK, Yuen H. Paradoxical development of brainstem tuberculoma during treatment for tuberculous meningitis. Hong Kong Med J 1996;2:211-2.
  • Chan CM, Yuen KY, Chan KS, Yam WC, Yim KHM, Ng WF, Ng MH. Single-tube nested polymerase chain reaction in the diagnosis of tuberculosis. J Clin Pathol 1996;49:290-4.
  • Yew WW, Chau CH. New antimycobacterial agents. Monaldi Arch Chest Dis 1996;51:394-404.
  • Tam CM. Tuberculosis in Hong Kong. Public Health & Epidemiology Bulletin 1996;5(4):25-8.
  • Yew WW. Pefloxacin and pulmonary tuberculosis. Tuberc Lung Dis 1996;77:194.

返回頁首

1995

  • Kapur V, Li LL, Hamrick MR, Plikaytis BB, Shinnick TM, Telenti A, Jacobs WR Jr, Banerjee A, Cole S, Yuen KY, et al. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing. Arch Pathol Lab Med 1995;119:131-8.
  • Yew WW, Chau CH, Wong PC, Lee J, Wong CF, Cheung SW, Chan CY, Cheng AF. Ciprofloxacin in the management of pulmonary tuberculosis in the face of hepatic dysfunction. Drugs Exp Clin Res 1995;21:79-83.
  • Chan CH, Lai CK, Leung JC, Ho AS, Lai KN. Elevated interleukin-2 receptor level in patients with active pulmonary tuberculosis and the changes following anti-tuberculosis chemotherapy. Eur Respir J 1995;8:70-3.
  • Wong PC, Yew WW, Wong CF, Choi HY. Ethambutol-induced pulmonary infiltrates with eosinophilia and skin involvement. Eur Respir J 1995;8:866-8.
  • Yew WW, Chau CH. Drug-resistant tuberculosis in the 1990s. Eur Respir J 1995;8:1184-92.
  • Dai DLK, LeeYC. Usefulness of the Mantoux test in screening for active pulmonary tuberculosis in the Hong Kong elderly. Hong Kong Med J 1995;1:195-200.
  • Chong LY, Lo KK. Cutaneous tuberculosis in Hong Kong: a 10-year retrospective study. Int J Dermat 1995;34:26-9.
  • Yuen KY, Chan CM, Chan KS, Yam WC, Ho PL, Chau PY. IS6110 based amplityping assay and RFLP fingerprinting of clinical isolates of Mycobacterium tuberculosis. J Clin Pathol 1995;48:924-8.
  • Chan CH, Or KK, Cheung W, Woo J. Adverse drug reactions and outcome of elderly patients on antituberculosis chemotherapy with and without rifampicin. J Med 1995;26:43-52.
  • Woo J, Chan C, Chan R, Cheung W, Or K, Chan K. Correlation between steady-state plasma concentration of antituberculous drugs and age, inclusion of rifampicin in the treatment regimen, adverse drug reactions and other clinical parameters. J Med 1995;26:279-94.
  • Hosker HSR, Lam CW, Ng TK, Ma HK, Chan SL. The prevalence and clinical significance of pulmonary infection due to non-tuberculous mycobacteria in Hong Kong. Respir Med 1995;89:3-8.
  • Ip MS, Yuen KY, Chiu EK, Chan JC, Lam WK, Chan TK. Pulmonary infections in bone marrow transplantation: the Hong Kong experience. Respiration 1995;62:80-3.
  • Yew WW, Wong CF, Lee J, Wong PC, Chau CH. Do beta-lactam-beta-lactamase inhibitor combinations have a place in the treatment of multidrug-resistant pulmonary tuberculosis? Tuberc Lung Dis 1995;76:90-2.
  • Yew WW, Chau CH, Wong PC, Choi HY. Ciprofloxacin-induced renal dysfunction in patients with mycobacterial lung infections. Tuberc Lung Dis 1995;76:173-5.
  • Yew WW, Lee J. Pathogenesis of cervical tuberculous lymphadenitis: pathways to anatomic localization. Tuber Lung Dis 1995;76:275-6.
  • Chan CH, Woo J, Or KK, Chan RC, Cheung W. The effect of age on the presentation of patients with tuberculosis. Tuberc Lung Dis 1995;76:290-4.

返回頁首

1994

  • Yew WW, Wong PC, Lee J, Chau CH. Ofloxacin and pulmonary tuberculosis. Chest 1994;105:1624.
  • Yew WW, Wong PC, Lee J, Wong CF. Rapid diagnosis of smear-negative pulmonary tuberculosis. Chest 1994;106:326-7.
  • Wong CF, Yew WW. Ethambutol-induced neutropenia and eosinophilia. Chest 1994;106:1638-9.
  • Yew WW, Chau CH, Lee J, Leung CW. Cholestatic hepatitis in a patient who received clarithromycin therapy for a Mycobacterium chelonae lung infection. Clin Infect Dis 1994;18:1025-6.
  • Yew WW, Chau CH, Tse LS. Does hospitalizing patients with tuberculosis ensure compliance with drug regimens? Clin Infect Dis 1994;19:554-5.
  • Chan SL, Yew WW, Porter JHD, McAdam KPWJ, Allen BW, Dickinson JM, Ellard GA, Mitchison DA. Comparison of Chinese and Western rifapentines and improvement of bioavailability by prior taking of various meals. Int J Antimicrob Agents 1994;3:267-74.
  • Yew WW, Piddock LJ, Li MS, Lyon D, Chan CY, Cheng AF. In-vitro activity of quinolones and macrolides against mycobacteria. J Antimicrob Chemother 1994;34:343-51.
  • Tsang DN, Li PC, Ho HF, Lai RW. Mycobacterial diseases and AIDS in Hong Kong. Journal of the Hong Kong Medical Association 1994;46:102-5.
  • Cheng AF, Li MS, Chan CY, Chan CH, Lyon D, Wise R, Lee JC. Evaluation of three culture media and their combinations for the isolation of Mycobacterium tuberculosis from pleural aspirates of patients with tuberculous pleurisy. J Trop Med Hyg 1994;97:249-53.
  • Hoheisel G, Chan KM, Chan HS, Chan KS, Teschler H, Costobel U. Endobronchial tuberculosis: diagnostic features and therapeutic outcome. Respir Med 1994;88:593-7.
  • Chan SL, Wong PC, Tam CM. 4-, 5- and 6-month regimens containing isoniazid, rifampicin, pyrazinamide and streptomycin for treatment of pulmonary tuberculosis under program conditions in Hong Kong. Tuberc Lung Dis 1994;75:245-50.
  • Chan KL, Chan HS, Lui SF, Lai KN. Recurrent acute pancreatitis induced by isoniazid. Tuberc Lung Dis 1994;75:383-5

返回頁首

1993

  • Tsui SY, Yew WW, Li MS, Chan CY, Cheng AF. Postantibiotic effects of amikacin and ofloxacin on Mycobacterium fortuitum. Antimicrob Agents Chemother 1993;37:1001-3.
  • Yew WW, Wong CF, Wong PC, Lee J, Chau CH. Adverse neurological reactions in patients with multidrug-resistant pulmonary tuberculosis after coadministration of cycloserine and ofloxacin. Clin Infect Dis 1993;17:288-9.
  • Yew WW, Wong PC, Woo HS, Yip CW, Chan CY, Cheng FB. Characterization of Mycobacterium fortuitum isolates from sternotomy wounds by antimicrobial susceptibilities, plasmid profiles, and ribosomal ribonucleic acid gene restriction patterns. Diagn Microbiol Infect Dis 1993;17:111-7.
  • Chan SL. Update on chemotherapy for tuberculosis. Hong Kong Pract 1993;15:2448-53.
  • Yew WW, Tam CM, Chan CY, Li MS, Cheng AF. Lack of activities of amikacin and sulphamethoxazole against Mycobacterium avium-intracellulare. Int J Clin Pharmacol Res 1993;13:65-8.
  • Yuen KY, Chan KS, Chan CM, Ho BS, Dai LK, Chau PY, Ng MH. Use of PCR in routine diagnosis of treated and untreated pulmonary tuberculosis. J Clin Path 1993;46:318-22.
  • Das S, Chan SL, Allen BW, Mitchison DA, Lowrie DB. Application of DNA fingerprinting with IS986 to sequential mycobacterial isolates obtained from pulmonary tuberculosis patients in Hong Kong before, during and after short-course chemotherapy. Tuberc Lung Disease 1993;74:47-5.

返回頁首

1992

  • Woo J, Chan HS. Therapeutic problems in the management of elderly patients with tuberculosis. Adverse Drug React Toxicol Rev 1992;11:13-8.
  • Hong Kong Chest Service/ Tuberculosis Research Centre, Madras/ British Medical Research Council. A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis 1992;145:36-41.
  • Yew WW, Lee J. Drug treatment of chronic tuberculous empyema. Chest 1992;101:1741-2.
  • Yew WW, Lau KS, Tse WK, Wong CF. Imipenem in the treatment of lung infections due to Mycobacterium fortuitum and Mycobacterium chelonae: further experience. Clin Infect Dis 1992;15:1046-7.
  • Yew WW, Lee J, Wong PC, Kwan SY. Tolerance of ofloxacin in the treatment of pulmonary tuberculosis in presence of hepatic dysfunction. Int J Clin Pharmacol Res 1992;12:173-8.
  • Woo J, Chan CH, Walubo A, Chan KK. Hydrazine--a possible cause of isoniazid--induced hepatic necrosis. J Med 1992;23:51-9.
  • Chan CHS, Chan RCY, Arnold M, Cheung H, Cheung SW, Cheng A. Bronchoscopy and tuberculostearic acid assay in the diagnosis of sputum smear-negative pulmonary tuberculosis: a prospective study with the addition of transbronchial biopsy. Q J Med 1992;82:15-23.
  • Chan SL, Yew WW, Ma WK, Girling DJ, Aber VR, Felmingham D, Allen BW, Mitchison DA. The early bactericidal activity of rifabutin measured by sputum viable counts in Hong Kong patients with pulmonary tuberculosis. Tuberc Lung Dis 1992;73:33-8.
  • Hong Kong Chest Service/ British Medical Research Council. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Tuberc Lung Dis 1992;73:59-67.

返回頁首

1991

  • Hong Kong Chest Service/ Tuberculosis Research Centre, Madras/ British Medical Research Council. A controlled clinical comparison of 6 and 8 months of antituberculosis chemotherapy in the treatment of patients with silicotuberculosis in Hong Kong. Am Rev Respir Dis 1991;143:262-7.
  • Hong Kong Chest Service/ British Medical Research Council. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampicin, and pyrazinamide. Results at 30 months. Am Rev Respir Dis 1991;143:700-6.
  • Yew WW, Lee J, Chan CY, Cheung SW, Wong PC, Kwan SY. Ofloxacin penetration into tuberculous pleural effusion. Antimicrob Agents Chemother 1991;35:2159-60.
  • Lau SK, Wei WI, Kwan S, Yew WW. Combined use of fine-needle aspiration cytologic examination and tuberculin skin test in the diagnosis of cervical tuberculous lymphadenitis. A prospective study. Arch Otolaryngol Head Neck Surg 1991;117:87-90.
  • Yew WW, Chan CY, Kwan SY, Cheung SW, French GL. Diagnosis of tuberculous pleural effusion by the detection of tuberculostearic acid in pleural aspirates. Chest 1991;100:1261-3.
  • Chan SL. Advances in the Diagnosis of Tuberculosis. JAMA SE Asia 1991;7:11-2.
  • Yew WW, Kwan SY, Wong PC, Fu KH. Percutaneous transthoracic needle biopsies in the rapid diagnosis of pulmonary tuberculosis. Lung 1991;169:285-9.
  • Walubo A, Chan K, Woo J, Chan HS, Wong CL. The disposition of antituberculous drugs in plasma of elderly patients I. Isoniazid and hydrazine metabolite. Methods Find Exp Clin Pharmacol 1991;13:545-50.
  • Walubo A, Chan K, Woo J, Chan HS, Wong CL. The disposition of antituberculous drugs in plasma of elderly patients II. Isoniazid, rifampicin and pyrazinamide. Methods Find Exp Clin Pharmacol 1991;13:551-6.
  • Chan CH, Arnold M, Chan CY, Mak TW, Hoheisel GB. Clinical and pathological features of tuberculous pleural effusion and its long-term consequences. Respiration 1991;58:171-5.
  • Yew WW, Lau KS, Ling MH. Phenytoin toxicity in a patient with isoniazid-induced hepatitis. Tubercle 1991;72:309-10.

返回頁首

1990

  • Chan SL, Reggiardo Z, Daniel TM, Girling DJ, Mitchison DA. Serodiagnosis of tuberculosis using an ELISA with antigen 5 and a hemagglutination assay with glycolipid antigens - results in patients with newly diagnosed pulmonary tuberculosis ranging in extent of disease from minimal to extensive. Am Rev Respir Dis 1990;142:385-90.
  • Chan HS, Pang J. Vasculitis in tuberculous infection. Chest 1990;98:511.
  • Kwan SY, Yew WW, Chan SL. Nosocomial tuberculosis in hospital staff. The size of the problem in a Hong Kong chest hospital. Chin Med J (Engl) 1990;103:909-14.
  • Wu JC, Lee SD, Yeh PF, Chan CY, Wang YJ, Huang YS, Tsai YT, Lee PY, Ting LP, Lo KJ. Isoniazid-rifampin-induced hepatitis in hepatitis B carriers. Gastroenterology 1990;98:502-4.
  • Yew WW, Kwan SY, Ma WK, Lui KS, Suen HC. Ofloxacin therapy of Mycobacterium fortuitum infection: further experience. J Antimicrob Chemother 1990;25:880-1.
  • Yew WW, Kwan SY, Ma WK, Khin MA, Chau PY. In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosis. J Antimicrob Chemother. 1990;26:227-36.
  • Chan SL. Editorial - Tuberculosis in Hong Kong - update. J Hong Kong Med Ass 1990;42:1.
  • Chan HS, Sun AJ, Hoheisel GB. Bronchoscopic aspiration and bronchoalveolar lavage in the diagnosis of sputum smear-negative pulmonary tuberculosis. Lung 1990;168:215-20.
  • Chan SL. Short course chemotherapy of tuberculosis. Medical Progress 1990;March:7-10.
  • Chan HS, Sun A, Hoheisel GB. Endobronchial tuberculosis--is corticosteroid treatment useful? A report of 8 cases and review of the literature. Postgrad Med J 1990;66:822-6.
  • Yew WW, Kwan SY, Wong PC, Lee J. Ofloxacin and imipenem in the treatment of Mycobacterium fortuitum and Mycobacterium chelonae lung infections. Tubercle 1990;71:131-3.
  • Humphries MJ, Teoh R, Lau J, Gabriel M. Factors of prognostic significance in Chinese children with tuberculous meningitis. Tubercle 1990;71:161-8.
  • Yew WW, Kwan SY, Ma WK, Lui KS .Minimal bactericidal and inhibitory concentrations of ofloxacin on Mycobacterium fortuitum at pH 7 and 5: therapeutic implications. Tubercle 1990;71:205-8.

返回頁首

1989

  • A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Hong Kong Chest Service/ Tuberculosis Research Centre, Madras/ British Medical Research Council. Am Rev Respir Dis 1989;139:871-6.
  • Acceptability, compliance, and adverse reactions when isoniazid, rifampin, and pyrazinamide are given as a combined formulation or separately during three-times-weekly antituberculosis chemotherapy. Hong Kong Chest Service/ British Medical Research Council. Am Rev Respir Dis 1989;140:1618-22.
  • Pang JA, Chan HS, Chan CY, Cheung SW, French GL. A tuberculostearic acid assay in the diagnosis of sputum smear-negative pulmonary tuberculosis. A prospective study of bronchoscopic aspirate and lavage specimens. Ann Intern Med 1989;111(8):650-4.
  • Yew WW, Kwan SY, Ma WK, Khin MA, Mok CK. Single daily-dose ofloxacin monotherapy for Mycobacterium fortuitum sternotomy infection. Chest 1989;96:1150-2.
  • Chan HS, Pang JA. Effect of corticosteroids on deterioration of endobronchial tuberculosis during chemotherapy. Chest 1989;96:1195-6.
  • Chan HS, Pang J. Isolated giant tuberculomata of the liver detected by computed tomography. Gastrointest Radiol 1989;14:305-7.

返回頁首

1988

  • Hawkins BR, Higgins DA, Chan SL, Lowrie DB, Mitchison DA, Girling DJ. HLA typing in the Hong Kong Chest Service/ British Medical Research Council study of factors associated with the breakdown to active tuberculosis of inactive pulmonary lesions. Am Rev Respir Dis 1988;138:1616-21.
  • Anti-TB regimens of chemotherapy - Recommendations from the Committee on treatment of the International Union against TB and lung disease. Bulletin of the International Union Against TB and Lung Disease (June 1988);63:60-64.
  • Woo J, Leung A, Chan K, Lai KN, Teoh R. Pyrazinamide and rifampicin regimens for patients on maintenance dialysis. Int J Artif Organs 1988;11:181-5.
  • Arnold M, Chan CY, Cheung SW, Van Hasselt CA, French GL. Diagnosis of nasopharyngeal tuberculosis by detection of tuberculostearic acid in formalin fixed, paraffin wax embedded tissue biopsy specimens. J Clin Pathol 1988;41:1334-6.

返回頁首

1987

  • Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/ British Medical Research Council. Am Rev Respir Dis 1987;136:1339-42.
  • Woo J, Wong CL, Teoh R, Chan K. Liquid chromatographic assay for the simultaneous determination of pyrazinamide and rifampicin in serum samples from patients with tuberculous meningitis. J Chromatogr. 1987;420:73-80.
  • French GL, Chan CY, Cheung SW, Oo KT. Diagnosis of pulmonary tuberculosis by detection of tuberculostearic acid in sputum by using gas chromatography-mass spectrometry with selected ion monitoring. J Infect Dis 1987;156:356-62.
  • French GL, Teoh R, Chan CY, Humphries MJ, Cheung SW, O'Mahony G. Diagnosis of tuberculous meningitis by detection of tuberculostearic acid in cerebrospinal fluid. Lancet 1987;2:117-9.

返回頁首

1986

  • Ellard GA, Ellard DR, Allen BW, Girling DJ, Nunn AJ, Teo SK, Tan TH, Ng HK, Chan SL. The bioavailability of isoniazid, rifampin, and pyrazinamide in two commercially available combined formulations designed for use in the short-course treatment of tuberculosis. Am Rev Respir Dis 1986;133:1076-80.
  • Yuen WC, Chan YF, Loke SL, Seto WH, Poon GP, Wong KK. Chronic lymphadenopathy caused by Penicillium marneffei: a condition mimicking tuberculous lymphadenopathy. Br J Surg 1986;73:1007-8.
  • A controlled trial of six-month and nine-month regimens of chemotherapy in patients undergoing radical surgery for tuberculosis of the spine in Hong Kong. Tenth report of the Medical Research Council Working Party on Tuberculosis of the Spine. Tubercle 1986;67:243-59.

返回頁首

1984

  • Hong Kong Chest Service/ Tuberculosis Research Centre, Madras/ British medical Research Council. A controlled trial of 2-month, 3-month, and 12-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 60months. Am Rev Respir Dis 1984;130:23-8.
  • Wong SH, Lau WY, Ho KK, Fan ST, Yiu TF, Chan SL. The management of urinary tuberculosis--a logical approach. Br J Urol 1984;56:349-53.
  • Wong SH, Lau WY, Poon GP, Fan ST, Ho KK, Yiu TF, Chan SL. The treatment of urinary tuberculosis. J Urol 1984;131:297-301
  • Hong Kong Chest Service/ BMRC. Study of a fully supervised programme of chemotherapy for pulmonary tuberculosis given once weekly in the continuation phase in the rural areas of Hong Kong. Tubercle 1984;65:5-15.
  • Survey of the previous investigation and treatment by private practitioners of patients with pulmonary tuberculosis attending government chest clinics in Hong Kong. Hong Kong Chest Service/ British Medical Research Council. Tubercle 1984;65:161-71.
  • Survey of patients presenting to the government chest service in Hong Kong and the effects of active tuberculosis case-finding by publicity campaigns. Hong Kong Chest Service/ British Medical Research Council. Tubercle 1984;65:173-84
  • Hong Kong Chest Service/ BMRC Survey of deaths in Hong Kong attributed to tuberculosis during a five-year period. Tubercle 1984;65:253-61

返回頁首

1983

  • Fox W. Compliance of patients and physicians: experience and lessons from tuberculosis-I. Br Med J (Clin Res Ed). 1983 Jul 2;287(6384):33-5.
  • Allen BW, Mitchison DA, Darbyshire J, Chew WW, Gabriel M. Examination of operation specimens from patients with spinal tuberculosis for tubercle bacilli. J Clin Pathol. 1983 Jun;36(6):662-6.
  • Allen BW, Mitchison DA, Chan YC, Yew WW, Allan WG, Girling DJ. Amikacin in the treatment of pulmonary tuberculosis. Tubercle 1983;64:111-8.

返回頁首

1982

  • A 10-year assessment of a controlled trial comparing debridement and anterior spinal fusion in the management of tuberculosis of the spine in patients on standard chemotherapy in Hong Kong. Eighth Report of the Medical Research Council Working Party on Tuberculosis of the Spine.
    J Bone Joint Surg Br 1982;64:393-8.
  • Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Second report: the results up to 24 months. Hong Kong Chest Service/ British Medical Research Council. Tubercle 1982;63:89-98.

返回頁首

1981

  • A controlled trial of a 2-month, 3-month, and 12-month regimens of chemotherapy for sputum smear-negative pulmonary tuberculosis: the results at 30 months. Hong Kong Chest Service/ Tuberculosis Research Centre, Madras/ British Medical Research Council. Am Rev Respir Dis 1981;124:138-42.
  • Controlled trial of four thrice-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Lancet 1981;1(8213):171-4.
  • Allan WG, Snell NJ, Hill LE, Fayers PM, Scadding JG, Fox W. A survey of deaths in Hong Kong attributed to tuberculosis. Tubercle 1981;62:1-11.
  • Hong Kong Chest Service/ TB Research Centre, Madras/ BMRC. A study of the characteristics and course of sputum smear-negative pulmonary tuberculosis. Tubercle 1981;62:155-67.
  • Jenner PJ, Ellard GA, Allan WG, Singh D, Girling DJ, Nunn AJ. Serum uric acid concentrations and arthralgia among patients treated with pyrazinamide-containing regimens in Hong Kong and Singapore. Tubercle 1981;62:175-9.

返回頁首

1980

  • A service program of antituberculosis chemotherapy with five drugs for four months in the treatment of drug addicts and prisoners with pulmonary tuberculosis in Hong Kong. Hong Kong Chest Service/British Medical Research Council. Am Rev Respir Dis 1980;122:417-24.

返回頁首

1979

  • Horsfall PA, Plummer J, Allan WG, Girling DJ, Nunn AJ, Fox W. Double blind controlled comparison of aspirin, allopurinol and placebo in the management of arthralgia during pyrazinamide administration. Tubercle. 1979 Mar;60(1):13-24.
  • Hong Kong Chest Service/ BMRC. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis: the results up to 24months. Tubercle 1979;60:201-10.
  • Allan WG, Girling DJ, Fayers PM, Fox W. The symptoms of newly diagnosed pulmonary tuberculosis and patients' attitudes to the disease and to its treatment in Hong Kong. Tubercle.1979;60:211-23.

返回頁首

1978

  • Hong Kong Chest Service/ BMRC. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report. Am Rev Respir Dis 1978;118:219-28.
  • Five-year assessments of controlled trials of ambulatory treatment, debridement and anterior spinal fusion in the management of tuberculosis of the spine. Studies in Bulawayo (Rhodesia) and in Hong Kong. Sixth report of the Medical Research Council Working Party on Tuberculosis of the Spine. J Bone Joint Surg Br 1978;60:163-77.

返回頁首

1977

  • Allan WG. Hong Kong tuberculosis treatment services/ British Medical Research Council Study of 6- and 9-month regimens of daily and intermittent streptomycin, isoniazid and pyrazinamide for pulmonary tuberculosis. Bull Int Union Tuberc 1976;51:91-3.
  • Dickinson JM, Mitchison DA, Lee SK, Ong YY, O'Mahoney MG, Girling DJ, Nunn AJ. Serum rifampicin concentration related to dose size and to the incidence of the 'flu' syndrome during intermittent rifampicin administration. J Antimicrob Chemother 1977;3:445-52.

返回頁首

1976

  • Allan WG. Hong Kong tuberculosis treatment services/ British Medical Research Council Study of 6- and 9-month regimens of daily and intermittent streptomycin, isoniazid and pyrazinamide for pulmonary tuberculosis. Bull Int Union Tuberc 1976;51:91-3.
  • Allan WG. A study of BCG at birth in Hong Kong. Bull Int Union Tuberc 1976;51:239-42.
  • Hong Kong TB Treatment Services, Singapore TB Service, Royal Postgraduate Medical School, Brompton Hospital, BMRC. Lack of association between rifampicin-dependent antibodies and bacteriological response during intermittent rifampicin treatment. J Antimicrob Chemother 1976;2:265-70.
  • Hong Kong TB Treatment Services and East African and BMRC. First-line chemotherapy in the retreatment of bacteriological relapses of pulmonary tuberculosis following a shortcourse regimen. Lancet 1976;1:162-3.
  • Hong Kong TB Treatment Services/ BMRC. Adverse reactions to short-course regimens containing streptomycin, isoniazid, pyrazinamide and rifampicin in Hong Kong. Tubercle 1976;57:81-95.

返回頁首

1975

  • Hong Kong TB Treatment Services/ BMRC Investigation. Investigations of allergic status and blood counts in Chinese patients receiving daily or iintermittent rifampicin in Hong Kong. Clin Allergy 1975;5:189-99.
  • Hong Kong TB Treatment Services/ BMRC. Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong. Tubercle 1975;56:81-96.
  • The influence of age and sex on the incidence of the 'flu' syndrome and rifampicin dependent antibodies in patients on intermittent rifampicin for tuberculosis. Hong Kong TB Treatment Services/ BMRC. Tubercle 1975;56:173-8.
  • Hong Kong TB Treatment Services/ Brompton Hospital/ BMRC. A controlled trial of daily and intermittent rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis: results up to 30 months. Tubercle 1975;56:179-89.

返回頁首

1974

  • A controlled trial of anterior spinal fusion and debridement in the surgical management of tuberculosis of the spine in patients on standard chemotherapy: a study in Hong Kong. Br J Surg 1974;61:853-66.
  • A controlled clinical trial of small daily doses of rifampicin in the prevention of adverse reactions to the drug in a once-weekly regimen of chemotherapy. A Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation. Clin Allergy 1974;4:1-12.
  • Allan WG. Practical policies in the control of tuberculosis in Hong Kong. Trop Doct 1974;4:178-83.
  • A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. A Hong Kong Tuberculosis Treatment Services/ Brompton Hospital/ British Medical Research Council investigation. Tubercle 1974;55:1-27.
  • A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regimens of chemotherapy for pulmonary tuberculosis-second report. A Hong Kong Tuberculosis Treatment Services/British Medical Research Council Investigation. Tubercle 1974;55:169-92.
  • Mitchison DA, Allen BW, Gabriel M, Nunn AJ. Sensitive microbiological method for the detection of rifampicin in urine. Tubercle 1974;55:245-8.

返回頁首

1973

  • Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Clinical observations on adverse reactions. Scand J Respir Dis Suppl 1973;84:119-24.
  • Allan WG. Tuberculosis in Hong Kong ten years later. Tubercle 1973;54:234-46.

返回頁首

1972

  • A study in Hong Kong to evaluate the role of pretreatment susceptibility tests in the selection of regiments of chemotherapy for pulmonary tuberculosis. Hong Kong Tuberculosis Treatment Services-British Medical Research Council Investigation. Am Rev Respir Dis 1972;106:1-22.
  • Aquinas M, Allan WG, Horsfall PA, Jenkins PK, Hung-Yan W, Girling D, Tall R, Fox W. Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong. Br Med J 1972;1:765-71.

返回頁首

1971

  • Aquinas M, Allan WG, Horsfall PA, Jenkins PK, Hung-Yan W, Girling D, Tall R, Fox W. Adverse reactions to daily and intermittent rifampicin regimens for pulmonary tuberculosis in Hong Kong. Br Med J 1972;1:765-71.
  • Allan WG, Tanaka A. A comparative study of different techniques of giving BCG vaccination to newborn infants in Hong Kong. Tubercle 1971;52:247-57.

返回頁首

1970

  • Mitchison DA, Allen BW, Miller AB. Detection of rifampicin in urine by a simple microbiological assay. Tubercle 1970;51:300-4.

返回頁首

1968

  • Hong Kong Anti-TB Association and Government TB Service/ BMRC investigation. A controlled comparison of thiacetazone (thioacetazone) plus isoniazid with PAS plus isoniazid in Hong Kong. Tubercle 1968;49:243-80.

返回頁首

1967

  • Moodie AS. Mass ambulatory chemotherapy in the treatment of tuberculosis in a predominantly urban community. Am Rev Respir Dis 1967;95:384-97.

返回頁首

1964

  • Pines A, Richardson RJ. Drug-resistance in patients with pulmonary tuberculosis presenting at chest clinics in Hong Kong. Tubercle 1964;45:77-95.
  • A report from the Research Committee of the British TB Association and the TB Treatment Services in Hong Kong. A controlled trial of ethionamide with isoniazid in the treatment of pulmonary tuberculosis in Hong Kong. Tubercle 1964;45:299-320.
  • Mitchison DA, Lloyd J. Comparison of the sensitivity to thiacetazone of tubercle bacilli from patients in Britain, east Africa, south India and Hong Kong. Tubercle 1964;45:360-9.

返回頁首

1963

  • Moodie AS. Tuberculosis in Hong Kong. Tubercle 1963;44:334-45.

返回頁首

1951

  • Moodie AS. Analysis and evaluation of tuberculosis in the British Crown Colony of Hong Kong. WHO/TBC/44;1951: P1-37.

返回頁首

1950

  • Lee HL. BCG vaccination against tuberculosis. Bull Hong Kong Chinese Med Ass 1950;43-8.

返回頁首

 

 

  
 
2007copyright logo | 重要告示 最近修訂日期: 二零零八年五月十九日